Impaired glutathione biosynthesis in the ischemic-reperfused rabbit myocardium  by Lapenna, Domenico et al.
FEBS Letters 391 (1996) 76-78 FEBS 17314 
Impaired glutathione biosynthesis in the ischemic-reperfused 
rabbit myocardium 
Domenico Lapenna a,*, Sergio de Gioia a, Giuliano Ciofani a, Andrea MezzettP, 
Sante D. Pierdomenico a, Carmine Di Ilio b, Franco Cuccurullo ~ 
~lstituto di Fisiopatologia Medica, Universita" 'G. D'Annunzio', Facolta" di Medicina e Chirurgia, 66100 ChietL Italy 
blstituto di Scienze Biochimiche, Universita' "G. D'Annunzio', Facolta' di Medicina e Chirurgia, 66100 ChietL Italy 
Received 19 June 1996 
Abstract Non-protein thiols (NP-SH) and the activities of the 
glutathione status-regulating enzymes y-glutamylcysteine synthe- 
tase (G-GCS), y-glutamyl transpeptidase (G-GT) and gin- 
tathione reductase (GR) were assessed in perfused rabbit hearts 
subjected to severe (60 rain) or mild (7 min) total ischemia and 30 
rain reperfusion. Severe ischemia significantly decreased NP-SH, 
which were further depressed on reperfusion together with a 
significant decline in G-GCS activity; G-GT and GR activities 
were unchanged. Specific analytes were unaffected by mild 
ischemia-reperfusion. Thus, impaired enzymatic biosynthesis of 
GSH is operative in the reperfused rabbit myocardium after 60 
rain ischemia. This phenomenon may favour myocardial GSH 
depression and oxidative reperfusion injury after severe ischemia. 
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I. Introduction 
Experimental studies have proved that myocardial ische- 
mia-reperfusion induces a decrease of tissue reduced glu- 
tathione (GSH) content, which has been attributed to oxida- 
tion and loss of the tripeptide from the injured myocytes [1,2]. 
Notably, cell GSH pool depression is relevant in conditioning 
myocardial oxidative injury [14]. Tissue levels of GSH are 
maintained via the activity of specific enzymes capable of 
favouring de novo biosynthetic processes and reconversion 
of GSH from its oxidized form, viz. ?-glutamylcysteine synthe- 
tase (G-GCS) and glutathione reductase (GR), respectively 
[5]. ?-Glutamyl transpeptidase (G-GT), which is a major 
GSH breakdown enzyme allowing tissue utilization of extra- 
cellular GSH, is also responsible for the regulation of GSH 
status in the cell environment [5]. 
In spite of the evidence of decreased GSH levels in the 
ischemic-reperfused myocardium, little is known concerning 
the activity of the aforementioned enzymes during ischemia- 
reperfusion of the mammalian heart. The present study, there- 
fore, was designed to investigate glutathione status-regulating 
enzymes in the ischemic and reperfused rabbit heart. 
2. Materials and methods 
2.1. Experimental protocol 
Hearts of New Zealand rabbits (body weight about 2.5 kg) were 
subjected to severe (60 min) or mild (7 min) ischemia followed or not 
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by 30 min reperfusion. The duration of the mild ischemic period was 
selected to induce unambiguously no myocyte irreversible damage and 
necrosis [6,7]. Moreover, when extrapolated to the clinical setting, the 
first protocol could be assimilated to prolonged ischemia with myo- 
cardial infarction, and the second to transient reversible ischemia, i.e. 
angina pectoris [6,7]. 
As far as the severe ischemia-reperfusion protocol is concerned, in a 
first control group of 6 rabbits, the excised hearts were perfused aero- 
bically for 110 min on a double-reservoir, Langendorff apparatus 
operating at 80 mmHg and kept at 37°C. The perfusion medium 
was a modified glucose-bicarbonate Kr bs-Henseleit buffer, contain- 
ing (in mM) 128 NaC1, 4.8 KC1, 1.2 KH2PO4, 2.4 CaC12, 1.2 MgSO4, 
25 NaHCO3, 11 glucose, and gassed with 95% 02 and 5% CO2 (pH 
7.4). Heart rate was kept constant at 180 beats/min by fight ventri- 
cular pacing. Contractile function was assessed via a fluid-filled latex 
balloon inserted into the left ventricular cavity through the mitral 
orifice and connected to a pressure transducer [8]. Developed pressure 
and end diastolic pressure were recorded on a Sensormedics Dyno- 
graph R 611 Recorder. Coronary flow was measured by 1 min perfu- 
sate collections [9]. When required, a rapid hypothermic arrest was 
obtained by cold buffer perfusion delivered by the second Langendorff 
reservoir. 
A second group of 6 hearts was subjected to 60 min total ischemia, 
after a preliminary period of 50 min perfusion with normally oxygen- 
ated buffer. 
A third group of 6 hearts was subjected to 60 min total ischemia, 
followed by 30 min reperfusion, after 20 min perfusion with normally 
oxygenated buffer. 
Three groups of 5 rabbits were used in the mild ischemia-reperfu- 
sion protocol; in this regard, the control hearts were perfused aero- 
bically for 110 min, while the ischemic and the ischemic-reperfused 
ones were subjected, respectively, to 7 min total ischemia fter 103 
min aerobic perfusion and to 7 min ischemia plus 30 rain reperfusion 
after 73 min aerobic perfusion. 
2.2. Biochemical analyses 
Reagents were from Sigma Aldrich s.r.l., Milano, Italy, unless 
otherwise indicated. Heart samples were homogenized (1:8 w/v) in 
ice-cold 0.1 M Tris-HC1 buffer, pH 7.7, plus 3 mM EDTA for enzy- 
matic study, or in 4% sulfosalicylic acid for the assay of non-protein 
thiol compounds (NP-SH). Centrifugations at400xg for 10 min and 
4500xg for 20 min were performed to assess, respectively, G-GT 
activity and NP-SH. Further centrifugations at 3500Xg for 20 min 
and 105 000 X g for 60 rain were performed to measure the activities of 
G-GCS and GR, respectively. 
The activity of G-GCS, the key enzyme catalyzing the first step in 
GSH biosynthesis [5,10], was assayed as described by Sekura and 
Meister [10], with slight modifications. Reaction mixtures contained 
10 mM L-glutamic acid, 20 mM DL-C~-aminobutyric a id, 5 mM 
Na2ATP and a suitable supernatant homogenate aliquot, in 80 mM 
Tris-HC1 buffer, pH 8.2, containing 4 mM EDTA, 10 [tg bovine 
serum albumin and 0.04 M MgC12. The inorganic phosphate (Pi) 
formed by the specific enzymatic activity was detected spectrophoto- 
metrically at 405 nm using a commercially available kit (Boehringer 
Mannheim, Germany). Results are expressed as ~tg Pi/min per mg 
protein. 
G-GT activity was determined using a commercial kit (Boehringer 
Mannheim, Germany), after 4 h incubation of the relative homogen- 
ate at 4°C in 0.1 M Tris-HC1 buffer, pH 8.2, containing 6 mM 
EDTA and 1% sodium deoxycholate [11]. Enzyme-mediated 5-ami- 
no-2-nitrobenzoate (ANB) formation was followed spectrophotomet- 
0014-5793/96/$12.00 © 1996 Federation of European Biochemical Societies. All rights reserved. 
P I ISO0 1 4 -5793(96)00705-3  
D. Lapenna et al./FEBS Letters 391 (1996) 76-78 
rically at 405 rim. Results are expressed asmU (nmol ANB released/ 
min) per mg protein. 
For GR activity assay, appropriate amounts of cytosol were added 
to 1.0 ml reaction mixtures containing 0.1 M potassium phosphate 
buffer, pH 7.4, 1.0 mM EDTA, 0.16 mM NADPH and 1.0 mM 
GSSG [12]. Blanks were without GSSG, and NADPH disappearance 
was followed spectrophotometrically at 340 nm. Results are expressed 
as mU (nmol NADPH oxidized/min) per mg protein (NADPH ex- 
tinction coefficient: 6220 M -1 cm-1). 
NP-SH, of which GSH represents virtually the only pool in the 
rodent myocardium [13], were measured spectrophotometrically at 
412 nm [12], after reaction of suitable aliquots of the relative super- 
natant homogenate with 0.6 mM 5,5'-dithiobis-2-nitrobenzoic acid 
(Ellman's reagent) in 0.2 M potassium phosphate buffer, pH 8.5, 
plus 1.0 mM EDTA. Values were calculated as nmol NP-SH/mg pro- 
tein, using an extinction coefficient of 13 600 M -1 cm -1 [12]. Protein 
concentrations were assayed according to Bradford [14]. 
2.3. Statistics 
Results were calculated as means + SD. Hemodynamic values ob- 
tained before and after ischemia-reperfusion were analyzed by paired 
Student's t-test [15]. Biochemical differences among the control, is- 
chemic and ischemic-reperfused h arts were computed by the one- 
way analysis of variance plus Bonferroni's test [15]. P<0.05 was 
regarded as statistically significant. 
3. Results 
In agreement with previous reports [1,2], severe ischemia 
induced a significant decrement of myocardial NP-SH levels 
(Table 1). Although G-GCS activity was decreased by about 
13% at the end of 60 min ischemia, the level of statistical 
significance was not reached; G-GT and GR activities were 
not changed by the ischemic period (Table 1). Reperfusion 
after severe ischemia was associated with a further decrement 
of myocardial NP-SH (P < 0.05), and with a significant de- 
pression of G-GCS activity (P<0.05; Table 1); G-GT and 
GR activities were also unaffected by reperfusion (Table 1). 
Regarding the mild ischemia-reperfusion protocol, NP-SH 
levels were similar in the control, ischemic and ischemic-re- 
perfused hearts (8.65+2.3, 8.4+ 1.7 and 8.5 + 1.6 nmol/mg 
protein, respectively, P= NS), as were also the activities of 
G-GCS (9.1+1.6, 8.9+2.1 and 8.8+1.8 gg Pi/min per mg 
protein, P = NS), G-GT (0.7 +_ 0.25, 0.68 + 0.2 and 0.73 + 0.3 
mU/mg protein, P=NS)  and GR (32.7+6.4, 33.2+7.6 and 
31.6 + 6.7 mU/mg protein, P = NS). 
Finally, in our experimental models, 60 min ischemia fol- 
lowed by 30 min reperfusion i duced a significant decrease in 
developed pressure (from 91.5_+6.5 to 24+4 mmHg, 
P<0.0001) and coronary flow values (from 4.6-+0.4 to 
2.2 -+ 0.35 ml/min per g wet tissue, P < 0.0001), as well as an 
end-diastolic pressure rise (62 + 5.5 mmHg), whereas the mild 
ischemia-reperfusion protocol did not affect significantly myo- 
cardial haemodynamics (not shown). 
4. Discussion 
The present study shows that severe, but not mild, ische- 
mia-reperfusion can significantly lower NP-SH (namely, 
GSH) levels and GSH enzymatic biosynthesis n the rabbit 
myocardium. In particular, severe ischemia, per se, results in 
a decreased myocardial GSH content, with a further decre- 
ment after reperfusion. Ischemia-induced GSH decrease is 
conceivably due to enhanced tripeptide oxidation and/or con- 
sumption [1,2], as well as to impaired energy-dependent GSH 
formation [5]. The further GSH decrement observed after re- 
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perfusion is in agreement with previous tudies carried out in 
perfused rabbit hearts subjected to severe ischemia-reperfu- 
sion [1,2]; this phenomenon may reflect GSH oxidation and 
loss from damaged myocytes [1,2]. It has been reported, how- 
ever, that the net amount of GSH released uring 30 min 
reperfusion does not quantitatively account for the cell GSH 
depression i duced by severe ischemia-reperfusion in the per- 
fused rabbit heart [2], and that in such a model mean cardiac 
GSSG levels rise of only 0.3 nmol/mg protein after 30 min 
reperfusion [1,2]. Thus, the impaired GSH enzymatic bio- 
synthesis of the reperfused myocardium, which represents a 
previously unrecognized finding, may contribute to tissue 
GSH depression after severe ischemia. In this context, studies 
performed with the G-GCS inhibitor buthionine sulfoximine 
(BSO) have shown that GSH concentrations are 40% lower in 
the perfused hearts of BSO-treated animals than in those of 
controls after ischemia-reperfusion [3].Hence, considering a 
substantial (approx. 70%) inhibition of G-GCS by BSO treat- 
ment in vivo [3] and the decrement of about 27% of G-GCS 
activity observed in our severe ischemia-reperfusion model, it 
may be calculated that such a decrement could have condi- 
tioned a 15% decline in heart GSH content. A similar G-GCS- 
related decline, although relatively small, might not be insig- 
nificant for the myocardium subjected to ischemia-reperfusion 
and oxidative stress [1]. Indeed, a decrement of only 30% of 
the cell GSH content induced right by G-GCS inhibition has 
been shown to cause a significant cell viability loss under 
oxidative stress conditions [16]. On the other hand, GSH is 
relevant in preventing mitochondrial dysfunction and de- 
rangement of cell calcium homeostasis [5,17], which are in- 
volved in the pathophysiology of irreversible ischemia-reper- 
fusion damage [7]. 
Reperfusion induces a burst of myocardial radical genera- 
tion and oxidant burden [8,18-20]. It is possible that radical 
species and lipid peroxidation by-products produced predomi- 
nantly at reperfusion after more prolonged cardiac ischernia 
[8,18] could interact with G-GCS at the thiol group level of 
the active site [5], resulting in some enzyme inactivation. Anti- 
oxidant enzymes may indeed be inactivated by radical species 
[21]. A significant myocardial loss of G-GCS appears unlikely, 
considering that G-GT and GR activities are unaffected by 
ischemia nd reperfusion, and that the molecular weight of 
these two latter enzymes is, respectively, lower than and very 
similar to that of G-GCS [5]. 
Therefore, reperfusion after severe ischemia induces a sig- 
Table 1 
Glutathione status-regulating enzymes and non-protein thiols in per- 
fused rabbit hearts subjected to 60 min total ischemia nd 30 rain 
reperfusion 
Control Ischemia Ischemia- 
reperfusion 
G-GCS 9.3 + 1.7 8.1 + 1.5 6.8 +_ 1.3 a 
G-GT 0.65+0.2 0.63+0.15 0.69+0.23 
GR 31.5 +5.7 30 +7.5 29 +6.3 
NP-SH 8.8 + 1.7 5.9 + 1.4 a 3.7 +0.9 a,b 
G-GCS, 7-glutamylcysteine synthetase activity (gg Pi/min per mg pro- 
tein); G-GT, ?-glutamyl transpeptidase activity (mU/mg protein); 
GR, glutathione reductase activity (mU/mg protein); NP-SH, non- 
protein thiols (nmol/mg protein). Means + S.D. of 6 hearts in each 
group. 
ap < 0.05 vs control (i.e., aerobic perfused) group. 
bp < 0.05 vs ischemia group (one-way analysis of variance followed by 
Bonferroni's test). See Section 2 for further explanations. 
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nificant depression of heart G-GCS activity, which may nega- 
tively influence cardiac GSH status and favour oxidative re- 
perfusion damage. Consistently, GSH and G-GCS have been 
stressed in myocardial cell protection against oxidant injury 
[22]. When extrapolated to the clinical setting, our data sug- 
gest that only reperfusion after severe ischemia, e.g. myocar- 
dial infarction with spontaneous and/or thrombolysis-induced 
reperfusion or prolonged cardiac arrest followed by reperfu- 
sion during heart surgery procedures, might be associated 
with a decline in myocardial GSH content and tripeptide bio- 
synthesis. Administration of GSH precursors without inhibi- 
tory effects on G-GCS, such as y-glutamylcysteine [17], could 
so be considered as cardioprotective agents in the clinical set- 
ting. Notably, the beneficial effect of y-glutamylcysteine ethyl 
ester, as a result of cell GSH preservation, has been proved in 
the canine myocardium subjected to severe ischemia and re- 
perfusion [23]. 
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